Testing violations of the exponential assumption in cancer clinical trials with survival endpoints
From MaRDI portal
Publication:5283334
Recommendations
- Optimality of testing procedures for survival data in the nonproportional hazards setting
- Adaptive designs for the one-sample log-rank test
- Exact tests for exponential regression
- Equivalence of two treatments and sample size determination under exponential survival model with censoring
- scientific article; zbMATH DE number 3960834
Cites work
- scientific article; zbMATH DE number 3795247 (Why is no real title available?)
- Chi-square goodness-of-fit test for randomly censored data
- Generalized Pearson-Fisher chi-square goodness-of-fit tests, with applications to models with life history data
- Goodness-of-fit tests for randomly censored data
- Pearson-Type Goodness-of-Fit Tests: The Univariate Case
- Recent and classical tests for exponentiality: a partial review with comparisons
- Small-Sample Properties of Censored-Data Rank Tests
- Testing to Determine the Underlying Distribution Using Randomly Censored Data
- The Price of Kaplan–Meier
- The Reduced Monotonic Regression Method
- What Price Kaplan-Meier?
Cited in
(1)
This page was built for publication: Testing violations of the exponential assumption in cancer clinical trials with survival endpoints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5283334)